|
1
|
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?
|
J Am Coll Cardiol
|
2011
|
4.12
|
|
2
|
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.
|
Circulation
|
2012
|
2.80
|
|
3
|
Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies.
|
Heart Rhythm
|
2010
|
2.19
|
|
4
|
Management of atrial fibrillation in chronic kidney disease: double trouble.
|
Am Heart J
|
2013
|
2.14
|
|
5
|
Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study.
|
J Am Coll Cardiol
|
2009
|
2.12
|
|
6
|
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation.
|
Eur Heart J
|
2008
|
1.98
|
|
7
|
Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites.
|
J Am Coll Cardiol
|
2009
|
1.98
|
|
8
|
Functional nature of electrogram fractionation demonstrated by left atrial high-density mapping.
|
Circ Arrhythm Electrophysiol
|
2012
|
1.90
|
|
9
|
Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mapping.
|
J Am Coll Cardiol
|
2013
|
1.88
|
|
10
|
Wolff-Parkinson-White ablation after a prior failure: a 7-year multicentre experience.
|
Europace
|
2010
|
1.88
|
|
11
|
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation.
|
J Am Coll Cardiol
|
2009
|
1.74
|
|
12
|
Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint.
|
Eur Heart J
|
2009
|
1.46
|
|
13
|
A practical criterion for the rapid detection of single-loop and double-loop reentry tachycardias.
|
J Cardiovasc Electrophysiol
|
2013
|
1.45
|
|
14
|
Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2008
|
1.37
|
|
15
|
Is there a potential benefit to increased irrigation channels during radiofrequency ablation? Results from a two-center prospective randomized study.
|
J Cardiovasc Electrophysiol
|
2011
|
1.37
|
|
16
|
Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation.
|
J Am Coll Cardiol
|
2010
|
1.18
|
|
17
|
Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia.
|
Europace
|
2008
|
1.14
|
|
18
|
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
|
PLoS One
|
2012
|
1.14
|
|
19
|
Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation.
|
J Cardiovasc Electrophysiol
|
2008
|
1.13
|
|
20
|
Peri-mitral atrial flutter in patients with atrial fibrillation ablation.
|
Heart Rhythm
|
2009
|
1.13
|
|
21
|
Remote magnetic navigation with irrigated tip catheter for ablation of paroxysmal atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.11
|
|
22
|
Initial results of efficacy of left linear ablation using a novel simultaneous multielectrode ablation catheter.
|
J Cardiovasc Electrophysiol
|
2011
|
1.11
|
|
23
|
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
|
Antimicrob Agents Chemother
|
2008
|
1.05
|
|
24
|
A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry.
|
J Cardiovasc Electrophysiol
|
2008
|
1.05
|
|
25
|
Advances in imaging for atrial fibrillation ablation.
|
Radiol Res Pract
|
2011
|
1.02
|
|
26
|
Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation.
|
Heart Rhythm
|
2011
|
0.97
|
|
27
|
Impact of pharmacological autonomic blockade on complex fractionated atrial electrograms.
|
J Cardiovasc Electrophysiol
|
2010
|
0.97
|
|
28
|
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.
|
Hypertension
|
2010
|
0.96
|
|
29
|
Prospective randomized comparison between the conventional electroanatomical system and three-dimensional rotational angiography during catheter ablation for atrial fibrillation.
|
Heart Rhythm
|
2010
|
0.96
|
|
30
|
A fortuitous syncope. The pitfalls of integrated bipolar defibrillator leads.
|
Indian Pacing Electrophysiol J
|
2008
|
0.94
|
|
31
|
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study.
|
Int J Hematol
|
2011
|
0.93
|
|
32
|
Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
|
Europace
|
2009
|
0.93
|
|
33
|
Early temporal and spatial regularization of persistent atrial fibrillation predicts termination and arrhythmia-free outcome.
|
Heart Rhythm
|
2011
|
0.91
|
|
34
|
Endocardial versus epicardial ventricular radiofrequency ablation: utility of in vivo contact force assessment.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.91
|
|
35
|
Combined identification of septal flash and absence of myocardial scar by cardiac magnetic resonance imaging improves prediction of response to cardiac resynchronization therapy.
|
J Interv Card Electrophysiol
|
2014
|
0.90
|
|
36
|
Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation.
|
J Interv Card Electrophysiol
|
2009
|
0.89
|
|
37
|
Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction.
|
Europace
|
2013
|
0.88
|
|
38
|
Wide complex tachycardia in a healthy young man.
|
Europace
|
2008
|
0.88
|
|
39
|
Emerging issues in the neuropsychology of HIV infection.
|
Curr HIV/AIDS Rep
|
2008
|
0.88
|
|
40
|
Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator.
|
Bioorg Med Chem Lett
|
2009
|
0.86
|
|
41
|
Tricyclic HIV integrase inhibitors: potent and orally bioavailable C5-aza analogs.
|
Bioorg Med Chem Lett
|
2008
|
0.86
|
|
42
|
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.
|
Eur Heart J
|
2010
|
0.86
|
|
43
|
Radiofrequency puncture of the fossa ovalis for resistant transseptal access.
|
Circ Arrhythm Electrophysiol
|
2008
|
0.86
|
|
44
|
Images in cardiovascular medicine. Novel technique to prevent left phrenic nerve injury during epicardial catheter ablation.
|
Circulation
|
2008
|
0.85
|
|
45
|
Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.84
|
|
46
|
The learning environment of paediatric trainees in New Zealand.
|
J Paediatr Child Health
|
2009
|
0.84
|
|
47
|
Catheter ablation of atrial tachycardia following atrial fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2009
|
0.84
|
|
48
|
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group.
|
Neuro Oncol
|
2005
|
0.83
|
|
49
|
Atrial tachycardias encountered in the context of catheter ablation for atrial fibrillation part ii: mapping and ablation.
|
Pacing Clin Electrophysiol
|
2009
|
0.83
|
|
50
|
Tricyclic HIV integrase inhibitors: VI. SAR studies of 'benzyl flipped' C3-substituted pyrroloquinolines.
|
Bioorg Med Chem Lett
|
2008
|
0.82
|
|
51
|
Biomineralization of selenium by the selenate-respiring bacterium Thauera selenatis.
|
Biochem Soc Trans
|
2012
|
0.82
|
|
52
|
Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
|
J Cardiovasc Electrophysiol
|
2014
|
0.82
|
|
53
|
Rational use of plasma protein and tissue binding data in drug design.
|
J Med Chem
|
2014
|
0.82
|
|
54
|
A pause for thought: exercise-induced sinus arrest causing syncope in a young male.
|
BMJ Case Rep
|
2011
|
0.81
|
|
55
|
Impact of patent foramen ovale on left atrial linear lesions in the context of atrial fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2011
|
0.80
|
|
56
|
Maintenance of atrial fibrillation by pulmonary vein tachycardia with ostial conduction block: evidence of an interpulmonary vein electrical connection.
|
J Cardiovasc Electrophysiol
|
2008
|
0.80
|
|
57
|
Relationship between perimitral and peritricuspid conduction times.
|
Heart Rhythm
|
2007
|
0.80
|
|
58
|
Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management.
|
Pacing Clin Electrophysiol
|
2009
|
0.79
|
|
59
|
Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety.
|
Bioorg Med Chem Lett
|
2009
|
0.79
|
|
60
|
The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis.
|
Front Physiol
|
2013
|
0.79
|
|
61
|
Utility of the lateral fluoroscopic view for subxiphoid pericardial access.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.78
|
|
62
|
Cross validation of the b Test in a large known groups sample.
|
Clin Neuropsychol
|
2012
|
0.78
|
|
63
|
Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view.
|
Europace
|
2008
|
0.77
|
|
64
|
Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a/b knockout mice.
|
Drug Metab Dispos
|
2014
|
0.77
|
|
65
|
Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
|
J Endocrinol
|
2011
|
0.77
|
|
66
|
Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.
|
Europace
|
2009
|
0.77
|
|
67
|
Tachyarrhythmias and catheter ablation in adult congenital heart disease.
|
Expert Rev Cardiovasc Ther
|
2014
|
0.77
|
|
68
|
Preprocedural clinical parameters determining perimitral conduction time during mitral isthmus line ablation.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.77
|
|
69
|
The substrate maintaining persistent atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2008
|
0.76
|
|
70
|
Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia.
|
Pathology
|
2013
|
0.76
|
|
71
|
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
|
Biomed Chromatogr
|
2014
|
0.76
|
|
72
|
Percutaneous extraction of cardiac implantable electronic devices (CIEDs) in octogenarians.
|
Pacing Clin Electrophysiol
|
2012
|
0.76
|
|
73
|
Subjective well-being and national satisfaction: taking seriously the "Proud of what?" question.
|
Psychol Sci
|
2011
|
0.75
|
|
74
|
Atrial bigeminy with recurrent supraventricular tachycardia.
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
|
75
|
Radiofrequency ablation: it is not just how hard you push but how you push.
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
|
76
|
Persistent atrial fibrillation presenting in sinus rhythm: pulmonary vein isolation versus pulmonary vein isolation plus electrogram-guided ablation.
|
Arch Cardiovasc Dis
|
2013
|
0.75
|
|
77
|
Re-examination of the Rey Word Recognition Test.
|
Clin Neuropsychol
|
2012
|
0.75
|
|
78
|
Ectopy and supraventricular tachycardia: is there a relationship?
|
Pacing Clin Electrophysiol
|
2012
|
0.75
|
|
79
|
A long conduction time in the coronary sinus: has mitral isthmus line been blocked?
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
|
80
|
Compensatory accessory pathway for complete atrioventricular block: 28-year follow-up.
|
Pacing Clin Electrophysiol
|
2009
|
0.75
|
|
81
|
Alternating RBBB and LBBB post-AV node ablation: what is the mechanism?
|
Pacing Clin Electrophysiol
|
2012
|
0.75
|
|
82
|
Scientific Opinion on Flavouring Group Evaluation 7, Revision 6 (FGE.07Rev6): saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids from chemical group 5.
|
EFSA J
|
2022
|
0.75
|
|
83
|
Utility of a Brief Open Source Test of Working Memory to Enhance Concussion Assessment and Management: 1923 Board #75 June 2, 3: 30 PM - 5: 00 PM.
|
Med Sci Sports Exerc
|
2016
|
0.75
|
|
84
|
Cycle length slowing during mitral isthmus ablation.
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
85
|
Has conduction to the pulmonary vein recovered?
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
86
|
A high performance and low-cost hole transporting layer for efficient and stable perovskite solar cells.
|
Phys Chem Chem Phys
|
2017
|
0.75
|
|
87
|
Extreme firing in a pulmonary vein during atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
|
88
|
Proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor.
|
J Gen Virol
|
2009
|
0.75
|
|
89
|
Ongoing tachycardia during cavotricuspid isthmus ablation: what is the mechanism?
|
J Cardiovasc Electrophysiol
|
2011
|
0.75
|
|
90
|
Opinion on the re-evaluation of starch sodium octenyl succinate (E 1450) as a food additive in foods for infants below 16 weeks of age and the follow-up of its re-evaluation as a food additive for uses in foods for all population groups.
|
EFSA J
|
2020
|
0.75
|
|
91
|
A typical atrioventricular accessory pathway?
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
92
|
Comparison of credible patients of very low intelligence and non-credible patients on neurocognitive performance validity indicators.
|
Clin Neuropsychol
|
2014
|
0.75
|
|
93
|
Spatial interaction in a multiuser immersive instrument.
|
IEEE Comput Graph Appl
|
2014
|
0.75
|
|
94
|
Safety evaluation of glucosylated steviol glycosides as a food additive in different food categories.
|
EFSA J
|
2022
|
0.75
|
|
95
|
Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat.
|
Drug Metab Lett
|
2016
|
0.75
|
|
96
|
Left atrial vagal stimulation resulting in atrial fibrillation driven from the right atrium.
|
Europace
|
2008
|
0.75
|
|
97
|
Mathematics summer schools for acoustics research training.
|
J Acoust Soc Am
|
2012
|
0.75
|
|
98
|
Double pericardial access facilitated by iatrogenic pneumopericardium.
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
|
99
|
Percutaneous transhepatic access for ablation of atypical atrial flutter in complex congenital heart disease.
|
J Cardiovasc Electrophysiol
|
2012
|
0.75
|
|
100
|
A chronic bile duct and intravenous cannulation model in conscious rabbits for pharmacokinetic studies.
|
J Invest Surg
|
2002
|
0.75
|
|
101
|
Unusual activation of the left atrium after ablation of a perimitral flutter: what is the mechanism?
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
102
|
Ablation of long-standing persistent atrial fibrillation with multielectrode ablation catheter.
|
Heart Rhythm
|
2010
|
0.75
|
|
103
|
Quantitative assessment of the effects of therapeutic hypothermia on early repolarization in idiopathic ventricular fibrillation survivors: a 7-year cohort study.
|
Circ Arrhythm Electrophysiol
|
2014
|
0.75
|
|
104
|
A rare complication from transseptal puncture-persistent aorto-right atrial shunt and puncture of noncoronary cusp of aortic valve.
|
Heart Rhythm
|
2011
|
0.75
|
|
105
|
Successful catheter ablation of a focal atrial tachycardia from the ascending aorta: a novel location and approach.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.75
|
|
106
|
Effect of Blend Composition on Binary Organic Solar Cells Using a Low Band Gap Polymer.
|
J Nanosci Nanotechnol
|
2015
|
0.75
|